Kaken Pharmaceutical , Ltd. Inventory

The latest inventory for KKPCF is $19B as of June 2026. That compares with $19B in the prior-year period — up 3.9% year over year. Investors often review this figure alongside Kaken Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, KKPCF's inventory moved from $19B to $19B — a 3.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kaken Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A inventory figure of $19B for KKPCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting KKPCF's inventory ($19B), review year-over-year change from $19B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.